ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

In Brief: Stephen Schimpff Accepts New Position Of Executive Vice President Of Univ. Of Maryland Medical System

October 4, 1985

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992